{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:34:09Z","timestamp":1777376049017,"version":"3.51.4"},"reference-count":13,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Am J Health Promot"],"published-print":{"date-parts":[[2023,9]]},"abstract":"\n Purpose<\/jats:title>\n To describe a 3-year demonstration project with selected Centers for Disease Control and Prevention National Comprehensive Cancer Control Program (NCCCP) award recipients to build partnerships with local organizations to improve knowledge and awareness of the association between injecting drugs and the risk for viral hepatitis and liver cancer, improve delivery of viral hepatitis services, and implement comprehensive syringe services programs.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n A mixed-methods descriptive evaluation of selected evidence-based interventions or promising strategies that each award recipient implemented based on the needs of their population.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n Selected provider and patient populations served by NCCCP award recipients in Iowa, Minnesota (American Indian Cancer Foundation), Mississippi, and West Virginia.<\/jats:p>\n <\/jats:sec>\n \n Subjects<\/jats:title>\n Four award recipients that implemented individually-tailored strategies and activities.<\/jats:p>\n <\/jats:sec>\n \n Measures<\/jats:title>\n Processes were assessed through monitoring and tracking tools. Challenges, lessons learned, and recommendations were collected via qualitative interviews.<\/jats:p>\n <\/jats:sec>\n \n Analysis<\/jats:title>\n We used descriptive statistics to analyze quantitative data. We analyzed award recipient interviews using thematic analysis.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Activities were implemented across four strategies. Strong public-private partnerships, ongoing technical assistance, a deep understanding of individual populations, and a shared commitment to remaining flexible were main factors.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n While challenges existed, award recipients implemented key strategies and activities in their populations. Findings contribute to the scaling of best practices to the larger cancer control community especially those whose populations are at higher risk for viral hepatitis.<\/jats:p>\n <\/jats:sec>","DOI":"10.1177\/08901171231182873","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T04:00:23Z","timestamp":1686283223000},"page":"982-987","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementing Promising Strategies to Reduce the Risk for Viral Hepatitis and Liver Cancer Among People Who Inject Drugs"],"prefix":"10.1177","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-4102","authenticated-orcid":false,"given":"Behnoosh","family":"Momin","sequence":"first","affiliation":[{"name":"Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Mezzo","sequence":"additional","affiliation":[{"name":"ICF, Fairfax, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Nielsen","sequence":"additional","affiliation":[{"name":"ICF, Fairfax, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayasha","family":"Richardson","sequence":"additional","affiliation":[{"name":"ICF, Fairfax, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin E.","family":"Conners","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"bibr1-08901171231182873","unstructured":"Centers for Disease Control and Prevention. Liver cancer. Liver cancer | CDC. Accessed November 16, 2022."},{"key":"bibr2-08901171231182873","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34479"},{"key":"bibr3-08901171231182873","unstructured":"Centers for Disease Control and Prevention. Hepatitis B surveillance in the United States. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2019surveillance\/HepB.htm. Accessed October 17, 2022."},{"key":"bibr4-08901171231182873","unstructured":"Centers for Disease Control and Prevention. Hepatitis C surveillance in the United States. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2019surveillance\/HepC.htm. Accessed October 17, 2022."},{"key":"bibr5-08901171231182873","volume-title":"A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report","author":"National Academies of Sciences","year":"2017"},{"key":"bibr6-08901171231182873","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2017.304132"},{"key":"bibr7-08901171231182873","unstructured":"Centers for Disease Control and Prevention. National comprehensive cancer control program. https:\/\/www.cdc.gov\/cancer\/ncccp\/index.htm. Accessed July 28, 2022."},{"key":"bibr8-08901171231182873","volume-title":"Statistics Data Visualizations Tool, Based on 2021 Submission Data (1999-2019)","author":"U.S. Cancer Statistics Working GroupU.S. Cancer"},{"key":"bibr9-08901171231182873","unstructured":"Centers for Disease Control and Prevention. Evidence-based strategies for preventing opioid overdose: What\u2019s working in the United States. Available at: https:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2018-evidence-based-strategies.pdf https:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2018-evidence-based-strategies.pdf. Accessed October 4, 2022."},{"key":"bibr10-08901171231182873","unstructured":"Project ECHO, The university of New Mexico. A revolution in medical education and care delivery: https:\/\/hsc.unm.edu\/echo\/. Accessed October 27, 2022."},{"key":"bibr11-08901171231182873","doi-asserted-by":"publisher","DOI":"10.5888\/pcd16.180671"},{"key":"bibr12-08901171231182873","doi-asserted-by":"publisher","DOI":"10.1177\/15248399211057154"},{"key":"bibr13-08901171231182873","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2013.301608"}],"container-title":["American Journal of Health Promotion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08901171231182873","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08901171231182873","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08901171231182873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:03:49Z","timestamp":1777367029000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.sagepub.com\/doi\/10.1177\/08901171231182873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1177\/08901171231182873"],"URL":"https:\/\/doi.org\/10.1177\/08901171231182873","relation":{},"ISSN":["0890-1171","2168-6602"],"issn-type":[{"value":"0890-1171","type":"print"},{"value":"2168-6602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,9]]}}}